Ratings Givaudan SA

Equities

GIVN

CH0010645932

Real-time Estimate Cboe Europe 05:50:38 2024-03-19 am EDT 5-day change 1st Jan Change
4,052 CHF -0.36% Intraday chart for Givaudan SA +1.71% +16.07%

Summary

  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The company returns high margins, thereby supporting business profitability.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.81 times its estimated earnings per share for the ongoing year.
  • Based on current prices, the company has particularly high valuation levels.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
+16.07% 42.31B
B+
+15.01% 65.22B
A-
-4.09% 47.89B
A-
-4.04% 17.18B
C+
+8.29% 16.54B
B+
-13.77% 14.64B
C+
+35.97% 13.39B
A-
+4.67% 8.77B
D+
-6.40% 8.34B
A
-38.18% 6.84B
B+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes